Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini Piramal

Piramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The company sees strong opportunities in the contract development and manufacturing segment. Piramal Pharma plans to expand existing businesses rather than acquire new ones. Macroeconomic uncertainty and rising interest rates pose potential risks.

Raccontata daeconomictimes.indiatimes.com